title: [Instrumental diagnosis for therapy decision making--what is possible and desirable, what is indispensible and what is superfluous in tumors of the pancreas?].
abstract: The spectrum of diagnostic procedures in patients with pancreatic malignancies today includes the patient's report and history, laboratory parameters, and modern techniques ranging from ERCP, EUS, CT, angiography, MRCP, and PET to molecular biology and parameters such as the cytological detection of ki-ras mutations. Anamnesis, laboratory parameters, tumor markers, ultrasound investigation, and ERCP are the relevant procedures for establishing the basic diagnosis of a pancreatic malignancy. MRCP will replace ERCP in most cases in future. EUS shows the highest accuracy in the diagnosis of vascular involvement by a pancreatic tumor.
authors.affiliation: Chirurgische Universitätsklinik Kiel.
authors.forename: B
authors.initials: B
authors.lastname: Kremer
authors.forename: D
authors.initials: D
authors.lastname: Henne-Bruns
authors.forename: H
authors.initials: H
authors.lastname: Grimm
mesh_terms: D003952:Diagnostic Imaging; D006801:Humans; D009367:Neoplasm Staging; D010179:Pancreas / Q000473:pathology; D010190:Pancreatic Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D011379:Prognosis; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics; D012680:Sensitivity and Specificity
chemical_list: C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)
vernacular_title: Apparative Diagnostik zur Therapieentscheidung--was ist möglich und wünschenswert, was unverzichtbar und was überflüssig bei Tumoren des Pankreas?